Deniz Aslan

Deniz Aslan

Auto-generated profile, based on publicly available information

Deniz Aslan

Division of Hematology Department of Pediatrics Faculty of Medicine Gazi University Ankara Türkiye

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2012 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
DADeniz Aslan
Deniz Aslan
RARustu F. Akata
Rustu F. Akata
HHHarriet Holme
Harriet Holme
TVTom Vulliamy
Tom Vulliamy
IDInderjeet Dokal
Inderjeet Dokal

22 September 2014 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
DADeniz Aslan
Deniz Aslan
RARustu Fikret Akata
Rustu Fikret Akata
JSJulia Schröder
Julia Schröder
RHRudolf Happle
Rudolf Happle
UMUte Moog
Ute Moog
OBOliver Bartsch
Oliver Bartsch

22 December 2017 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
DADeniz Aslan
Deniz Aslan
RARüştü Fikret Akata
Rüştü Fikret Akata


25 June 2015 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
DADeniz Aslan
Deniz Aslan
NANajim Ameziane
Najim Ameziane
JWJohan P. De Winter
Johan P. De Winter
Fanconi anemia (FA) is an inherited disorder characterized by malformations, marrow failure, and predisposition to cancer. Birth defects and laboratory features are characteristic and helpful in diagnosis, when present. Chromosome fragility is pathognomonic in the diagnosis. However, in some cases, there are no obvious physical anomalies or suggestive hematologic abnormalities, and inconclusive diagnostic tests have also been described. In such cases, a molecular diagnosis is required. This approach presents some advantages, especially in populations with a high incidence of FA and of consanguinity. Herein, we present a case with mild phenotypic features, inconclusive hematological findings and a negative breakage test. The diagnosis of FA was confirmed with next-generation sequencing. To our knowledge, this is the first publication of a FA patient being molecularly diagnosed utilizing this method since its introduction. Given its technical and financial features, we suggest that next-generation sequencing might be an alternative first-line diagnostic test for selected cases from particular populations.

27 December 2017 in Mediterranean Journal of Hematology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
DADeniz Aslan
Deniz Aslan
Formulas for the Detection β-Thalassemia Carriers Are Affected by Changes in Red Cell Parameters